Table 2. Advantages and disadvantages of non-viral vector delivery systems.
Advantages | Disadvantages | |
---|---|---|
| ||
Naked siRNA | Effective in certain organs. Lower toxicity and inflammatory responses. Simple formulation. | Lack of stability. |
Chemically modified siRNA | Easily formulated. Medium efficiency. Lower immune response. | Impaired bioactivity. High Cost. Toxicity. Inflammatory response. |
Liposome modified siRNA | Stable, variable, flexible and multifunctional. Easy to formulate. Biodegradable. No immune response and non-toxic in neutral liposome. More effective in cationic liposomes. | Low specificity. Low efficiency in neutral lipids. Inflammatory results with cationic lipids. |
Nanoparticles | High stability. Decreased non-specific bio-distribution. Induces non-specific endocytosis. | Cell toxicity |